These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


141 related items for PubMed ID: 26983

  • 21. Augmented venous return: protection of the ischemic myocardium during endotoxemia.
    Hess ML, Komwatana P, Krause S, Bruni FD.
    Adv Shock Res; 1979; 2():257-75. PubMed ID: 162474
    [Abstract] [Full Text] [Related]

  • 22. Endotoxin shock in newborn dogs: serial hemodynamic studies.
    Goto M, Griffin AJ, Chiemmongkoltip P, Onouchi Z, Bernheim B.
    J Lab Clin Med; 1988 Jul; 112(1):109-17. PubMed ID: 3392454
    [Abstract] [Full Text] [Related]

  • 23. Cell therapy with a tissue-engineered kidney reduces the multiple-organ consequences of septic shock.
    Humes HD, Buffington DA, Lou L, Abrishami S, Wang M, Xia J, Fissell WH.
    Crit Care Med; 2003 Oct; 31(10):2421-8. PubMed ID: 14530746
    [Abstract] [Full Text] [Related]

  • 24. Regional effects of dobutamine in endotoxic shock.
    De Backer D, Zhang H, Manikis P, Vincent JL.
    J Surg Res; 1996 Oct; 65(2):93-100. PubMed ID: 8903453
    [Abstract] [Full Text] [Related]

  • 25. A model of ovine endotoxemia characterized by an increased cardiac output.
    Talke P, Dunn A, Lawlis L, Sziebert L, White A, Herndon D, Flynn JT, Traber D.
    Circ Shock; 1985 Oct; 17(2):103-8. PubMed ID: 3902275
    [Abstract] [Full Text] [Related]

  • 26. Lack of beneficial effects of milrinone in severe septic shock.
    Lindgren S, Almqvist P, Arvidsson D, Montgomery A, Andersson KE, Haglund U.
    Circ Shock; 1990 Aug; 31(4):365-75. PubMed ID: 2204496
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cardiovascular effects of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydrochloride (546C88) in patients with septic shock: results of a randomized, double-blind, placebo-controlled multicenter study (study no. 144-002).
    Watson D, Grover R, Anzueto A, Lorente J, Smithies M, Bellomo R, Guntupalli K, Grossman S, Donaldson J, Le Gall JR, Glaxo Wellcome International Septic Shock Study Group.
    Crit Care Med; 2004 Jan; 32(1):13-20. PubMed ID: 14707555
    [Abstract] [Full Text] [Related]

  • 30. The duration of hypotension before the initiation of antibiotic treatment is a critical determinant of survival in a murine model of Escherichia coli septic shock: association with serum lactate and inflammatory cytokine levels.
    Kumar A, Haery C, Paladugu B, Kumar A, Symeoneides S, Taiberg L, Osman J, Trenholme G, Opal SM, Goldfarb R, Parrillo JE.
    J Infect Dis; 2006 Jan 15; 193(2):251-8. PubMed ID: 16362889
    [Abstract] [Full Text] [Related]

  • 31. Splanchnic oxygen consumption in septic and hemorrhagic shock.
    Arvidsson D, Rasmussen I, Almqvist P, Niklasson F, Haglund U.
    Surgery; 1991 Feb 15; 109(2):190-7. PubMed ID: 1899492
    [Abstract] [Full Text] [Related]

  • 32. Lack of significant protection afforded by heparin during endotoxic shock.
    Priano LL, Wilson RD, Traber DL.
    Am J Physiol; 1971 Apr 15; 220(4):901-5. PubMed ID: 5551144
    [No Abstract] [Full Text] [Related]

  • 33. The role of fibrin formation in the pathogenesis of bacteremic shock in the primate.
    Hammon JW, Kitzmiller JL, Virgillio R, Getz LG, Lucas WE.
    Surg Gynecol Obstet; 1978 Apr 15; 146(4):535-40. PubMed ID: 24899
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. The haemodynamic effects of quazodine, a cardiac stimulant, in experimental E. coli endotoxin shock in the cat.
    Parratt JR, Winslow E.
    Clin Exp Pharmacol Physiol; 1974 Apr 15; 1(1):31-41. PubMed ID: 4616780
    [No Abstract] [Full Text] [Related]

  • 36. The surgical implications of physiologic patterns in myocardial infarction shock.
    Siegel JH, Farrell EJ, Goldwyn RM, Friedman HP.
    Surgery; 1972 Jul 15; 72(1):126-41. PubMed ID: 5033188
    [No Abstract] [Full Text] [Related]

  • 37. A new canine model of endotoxin shock.
    Evans SF, Hinds CJ, Varley JG.
    Br J Pharmacol; 1984 Oct 15; 83(2):433-42. PubMed ID: 6435710
    [Abstract] [Full Text] [Related]

  • 38. Pattern and process in the evolution of human septic shock.
    Siegel JH, Goldwyn RM, Friedman HP.
    Surgery; 1971 Aug 15; 70(2):232-45. PubMed ID: 5560184
    [No Abstract] [Full Text] [Related]

  • 39. Physiologic mechanisms in clinical shock.
    Shoemaker WC.
    Adv Exp Med Biol; 1971 Oct 15; 23(0):57-75. PubMed ID: 5164835
    [No Abstract] [Full Text] [Related]

  • 40. Cardiorespiratory alterations in unanesthetized dogs due to gram-negative bacterial endotoxin.
    Priano LL, Wilson RD, Traber DL.
    Am J Physiol; 1971 Mar 15; 220(3):705-11. PubMed ID: 5545680
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.